WO2002009734A1 - Inhibiteurs d'absorption de sucre et leur procede de production - Google Patents

Inhibiteurs d'absorption de sucre et leur procede de production Download PDF

Info

Publication number
WO2002009734A1
WO2002009734A1 PCT/JP2001/006436 JP0106436W WO0209734A1 WO 2002009734 A1 WO2002009734 A1 WO 2002009734A1 JP 0106436 W JP0106436 W JP 0106436W WO 0209734 A1 WO0209734 A1 WO 0209734A1
Authority
WO
WIPO (PCT)
Prior art keywords
evening primrose
absorption inhibitors
sugar absorption
primrose seeds
defatted
Prior art date
Application number
PCT/JP2001/006436
Other languages
English (en)
French (fr)
Other versions
WO2002009734A8 (fr
Inventor
Yotaro Konishi
Michio Aitani
Hiroshi Yamaguchi
Tsutomu Arimura
Tadashi Okada
Hiromichi Murai
Original Assignee
Oryza Oil & Fat Chemical Co.,Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oryza Oil & Fat Chemical Co.,Ltd. filed Critical Oryza Oil & Fat Chemical Co.,Ltd.
Priority to US10/343,488 priority Critical patent/US6932990B2/en
Priority to EP01954345A priority patent/EP1312374B1/en
Priority to AU2001276682A priority patent/AU2001276682A1/en
Priority to JP2002515287A priority patent/JP4873824B2/ja
Priority to DE60135760T priority patent/DE60135760D1/de
Publication of WO2002009734A1 publication Critical patent/WO2002009734A1/ja
Publication of WO2002009734A8 publication Critical patent/WO2002009734A8/ja
Priority to US10/803,873 priority patent/US20060024396A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
PCT/JP2001/006436 2000-08-01 2001-07-26 Inhibiteurs d'absorption de sucre et leur procede de production WO2002009734A1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US10/343,488 US6932990B2 (en) 2000-08-01 2001-07-26 Carbohydrate absorption inhibitor and method for manufacturing the same
EP01954345A EP1312374B1 (en) 2000-08-01 2001-07-26 Primrose seed extracts as sugar absorption inhibitors and process for producing the same
AU2001276682A AU2001276682A1 (en) 2000-08-01 2001-07-26 Sugar absorption inhibitors and process for producing the same
JP2002515287A JP4873824B2 (ja) 2000-08-01 2001-07-26 糖質吸収阻害剤およびその製造方法
DE60135760T DE60135760D1 (de) 2000-08-01 2001-07-26 Nachtkerzensamenextrakte als inhibitoren der zuckerabsorption und deren herstellungsprozess
US10/803,873 US20060024396A1 (en) 2000-08-01 2004-03-19 Method of treating diabetes and obesity using carbohydrate absorption inhibitors

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000-232930 2000-08-01
JP2000232930 2000-08-01

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/803,873 Division US20060024396A1 (en) 2000-08-01 2004-03-19 Method of treating diabetes and obesity using carbohydrate absorption inhibitors

Publications (2)

Publication Number Publication Date
WO2002009734A1 true WO2002009734A1 (fr) 2002-02-07
WO2002009734A8 WO2002009734A8 (fr) 2002-02-28

Family

ID=18725531

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2001/006436 WO2002009734A1 (fr) 2000-08-01 2001-07-26 Inhibiteurs d'absorption de sucre et leur procede de production

Country Status (8)

Country Link
US (2) US6932990B2 (ja)
EP (1) EP1312374B1 (ja)
JP (1) JP4873824B2 (ja)
CN (1) CN1268351C (ja)
AT (1) ATE407689T1 (ja)
AU (1) AU2001276682A1 (ja)
DE (1) DE60135760D1 (ja)
WO (1) WO2002009734A1 (ja)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030075947A (ko) * 2002-03-19 2003-09-26 제네티카 주식회사 신 혈관형성을 억제하는 물질
WO2004009094A1 (en) * 2002-07-24 2004-01-29 Ohio University Methods and compositions for treating diabetes mellitis
JP2004352644A (ja) * 2003-05-29 2004-12-16 Oriza Yuka Kk 抗ピロリ菌組成物
WO2005032570A1 (ja) * 2003-10-06 2005-04-14 Oryza Oil & Fat Chemical Co., Ltd. ダイエット用組成物
JP2006001872A (ja) * 2004-06-16 2006-01-05 Kanebo Ltd α−グルコシダーゼ阻害剤及びそれを用いた食品
JP2006056850A (ja) * 2004-08-23 2006-03-02 Suntory Ltd リパーゼ阻害剤
WO2006030929A1 (en) * 2004-09-13 2006-03-23 Chuon Co., Ltd. Carbohydrase inhibitors derived from chestnut and use thereof
WO2006030567A1 (en) * 2004-09-13 2006-03-23 Chuon Co., Ltd. Carbohydrase inhibitors derived from fagaceous plants and use thereof
JP2006335758A (ja) * 2003-10-06 2006-12-14 Oriza Yuka Kk ダイエット用組成物
JP2007518420A (ja) * 2004-01-26 2007-07-12 エヌ．ブイ．・ヌートリシア アミラーゼによって誘発される澱粉分解を阻害することに基づく、改善された半固体食品及びその製造方法
JP2010184909A (ja) * 2009-02-13 2010-08-26 Rheology Kino Shokuhin Kenkyusho:Kk 機能性組成物およびこの組成物を含有する医薬又は健康食品
US20110021417A1 (en) * 2003-09-19 2011-01-27 Rhoades Jonathan Robert Compositions comprising oligosaccharides
JP2014198684A (ja) * 2013-03-29 2014-10-23 サンスター株式会社 血糖代謝改善剤
WO2019131759A1 (ja) * 2017-12-27 2019-07-04 サントリーホールディングス株式会社 腸管バリア機能改善用組成物
JP6998108B2 (ja) 2016-03-07 2022-01-18 株式会社ダイセル ウロリチン類を含有するα－グルコシダーゼ活性阻害剤、およびウロリチン類を含有する血糖値上昇抑制剤
WO2022085602A1 (ja) * 2020-10-20 2022-04-28 サントリーホールディングス株式会社 Ｔｇｒ５活性化用組成物

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US7713546B1 (en) * 2001-04-03 2010-05-11 Soft Gel Technologies, Inc. Corosolic acid formulation and its application for weight-loss management and blood sugar balance
US7666459B2 (en) * 2001-09-12 2010-02-23 The Procter & Gamble Company Pet food compositions
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050251265A1 (en) * 2004-05-07 2005-11-10 Calandruccio James H Trapezium implant for thumb and method
US20090252834A1 (en) * 2004-05-10 2009-10-08 Michael Griffin Hayek Compositions comprising glucose anti-metabolites
US20050249837A1 (en) * 2004-05-10 2005-11-10 The Procter & Gamble Company Processes for preparing plant matter extracts and pet food compositions
WO2005117608A1 (en) * 2004-06-04 2005-12-15 Horizon Science Pty Ltd Natural sweetener
JP2006016330A (ja) * 2004-06-30 2006-01-19 Suntory Ltd 脂肪燃焼促進剤
US20060051435A1 (en) * 2004-08-19 2006-03-09 Udell Ronald G Nutritional supplement for body fat reduction
DE602005020646D1 (de) * 2004-08-30 2010-05-27 Takeda Pharmaceutical Screening-verfahren
DK1880001T3 (da) 2005-05-31 2011-09-12 Iams Company Feline probiotiske lactobacilli
CA2607949C (en) 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria
MX2007014586A (es) 2005-06-03 2008-02-05 Horizon Science Pty Ltd Sustancias que tienen propiedades de redistribucion de masa corporal.
US20070036874A1 (en) * 2005-08-05 2007-02-15 Litao Zhong Compositions and methods for controlling glucose and lipid uptake from foods
KR100829083B1 (ko) 2006-07-28 2008-05-16 재단법인 제주하이테크산업진흥원 생리활성을 갖는 애기달맞이 추출물
MX2009002413A (es) * 2006-09-19 2009-03-20 Horizon Science Pty Ltd Extractos derivados de la caña de azucar y un proceso para su manufactura.
EP2124969A2 (en) * 2007-02-01 2009-12-02 The Iams Company Method for decreasing inflammation and oxidative stress in mammals
AU2008211600B8 (en) * 2007-02-01 2014-02-13 Mars, Incorporated Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
EP2303252A1 (en) 2008-05-15 2011-04-06 Alois Jungbauer Compounds for the treatment of metabolic syndrome and insulin resistance
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2957286B1 (en) * 2008-08-22 2018-11-21 Vifor (International) Ltd. Compositions comprising crosslinked cation exchange polymers and use in treating hyperkalemia
TWI444195B (zh) * 2008-10-08 2014-07-11 Pokka Corp Anti-avian influenza virus agents and products containing anti-avian influenza virus agents
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
CN102018766B (zh) 2009-09-16 2013-03-06 博仲盛景医药技术（北京）有限公司 一种植物提取物、其提取方法和用途及含有这种提取物的组合物
AU2012214104C1 (en) 2011-02-08 2017-08-03 Poly Gain Pte Ltd Sugar extracts
RU2451506C1 (ru) * 2011-06-02 2012-05-27 Сергей Юрьевич Лешков Комбинация для лечения сахарного диабета и его осложнений
JP6239622B2 (ja) 2012-08-28 2017-11-29 ザ プロダクト メーカーズ （オーストラリア） プロプライエタリー リミテッド 抽出方法
CN105722520A (zh) 2013-08-16 2016-06-29 产品制造商（澳大利亚）有限公司 甘蔗衍生提取物及治疗方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0423419A1 (en) * 1989-10-19 1991-04-24 Mitsui Norin Co., Ltd. Inhibitive agent against activity of alpha-amylase
WO1997023210A1 (fr) * 1995-12-26 1997-07-03 Suntory Limited Agent anti-obesite dont le principe actif est la procyanidine
JPH09176019A (ja) * 1995-12-26 1997-07-08 Suntory Ltd 糖質分解消化酵素阻害剤並びにこれを配合した医薬品および飲食品
WO2000018416A1 (en) * 1998-09-30 2000-04-06 Industrial Research Limited Antioxidant compositions and process for their preparation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0423419A1 (en) * 1989-10-19 1991-04-24 Mitsui Norin Co., Ltd. Inhibitive agent against activity of alpha-amylase
WO1997023210A1 (fr) * 1995-12-26 1997-07-03 Suntory Limited Agent anti-obesite dont le principe actif est la procyanidine
JPH09176019A (ja) * 1995-12-26 1997-07-08 Suntory Ltd 糖質分解消化酵素阻害剤並びにこれを配合した医薬品および飲食品
WO2000018416A1 (en) * 1998-09-30 2000-04-06 Industrial Research Limited Antioxidant compositions and process for their preparation

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ARAKI HIROKO ET AL.: "Effects of polyphenols on the activities of salivary and pancreatic alpha-amylases", KIYO-SEITOKU EIYO TANKI DAIGAKU, vol. 25, 1994, pages 15 - 20, XP002948559 *
CANNEL RICHARD J.P.: "Purification and characterization of pentagalloylglucose, an alpha-glucosidase inhibitor/antibiotic from the freshwater green alga spirogyra varians", BIOCHEM. J., vol. 255, no. 3, pages 937 - 941, XP002948558 *
CHEMICAL ABSTRACTS, vol. 124, no. 23, 1996, Columbus, Ohio, US; abstract no. 124:312296, LU FEI ET AL.: "Phenolic antioxidant components of evening primrose" page 694; XP002948562 *
HONDA MIWA ET AL.: "Inhibition of rat small intestinal sucrase and alpha-glucosidase activities by tea polyphenols", BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, vol. 57, no. 1, 1993, pages 123 - 124, XP002948557 *
QUESADA CRISTINA ET AL.: "Phenolic inhibitors of alpha-amylase ans trypsin enzymes by extracts from pears, lentils and cocoa", J. FOOD PROTECTION, vol. 59, no. 2, 1996, pages 185 - 192, XP002948556 *
SHAHIDI FEREIDOON ET AL.: "Antioxidant activity of phenolic extracts of evening primrose(oenothera biennis): a preliminary study", J. FOOD LIPIDS, vol. 4, no. 2, 1997, pages 75 - 86, XP002948560 *
WETTASINGHE MAHINDA ET AL.: "Evening primrose meal: A source of natural antioxidants and scavenger og hydrogen peroxide and oxygen-derived free radicals", J. AGRIC. FOOD CHEM., vol. 47, no. 5, pages 1801 - 1812, XP002948561 *

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030075947A (ko) * 2002-03-19 2003-09-26 제네티카 주식회사 신 혈관형성을 억제하는 물질
WO2004009094A1 (en) * 2002-07-24 2004-01-29 Ohio University Methods and compositions for treating diabetes mellitis
JP4541662B2 (ja) * 2003-05-29 2010-09-08 オリザ油化株式会社 抗ピロリ菌組成物
JP2004352644A (ja) * 2003-05-29 2004-12-16 Oriza Yuka Kk 抗ピロリ菌組成物
US20110021417A1 (en) * 2003-09-19 2011-01-27 Rhoades Jonathan Robert Compositions comprising oligosaccharides
US8802164B2 (en) 2003-10-06 2014-08-12 Oryza Oil & Fat Chemical Co., Ltd. Method for promoting carnitine palmitoyltransferase activity using green coffee bean extract
JP4499665B2 (ja) * 2003-10-06 2010-07-07 オリザ油化株式会社 ダイエット用組成物
WO2005032570A1 (ja) * 2003-10-06 2005-04-14 Oryza Oil & Fat Chemical Co., Ltd. ダイエット用組成物
JPWO2005032570A1 (ja) * 2003-10-06 2007-11-15 オリザ油化株式会社 ダイエット用組成物
JP2006335758A (ja) * 2003-10-06 2006-12-14 Oriza Yuka Kk ダイエット用組成物
JP2007518420A (ja) * 2004-01-26 2007-07-12 エヌ．ブイ．・ヌートリシア アミラーゼによって誘発される澱粉分解を阻害することに基づく、改善された半固体食品及びその製造方法
JP2006001872A (ja) * 2004-06-16 2006-01-05 Kanebo Ltd α−グルコシダーゼ阻害剤及びそれを用いた食品
WO2006022227A1 (ja) * 2004-08-23 2006-03-02 Suntory Limited リパーゼ阻害剤
JP2006056850A (ja) * 2004-08-23 2006-03-02 Suntory Ltd リパーゼ阻害剤
JP2008512345A (ja) * 2004-09-13 2008-04-24 隆廣 辻田 栗由来の糖質分解酵素阻害物質、及びその用途
JP2006104181A (ja) * 2004-09-13 2006-04-20 Takahiro Tsujita ブナ科植物由来の糖質分解酵素阻害物質、及びその用途
WO2006030567A1 (en) * 2004-09-13 2006-03-23 Chuon Co., Ltd. Carbohydrase inhibitors derived from fagaceous plants and use thereof
WO2006030929A1 (en) * 2004-09-13 2006-03-23 Chuon Co., Ltd. Carbohydrase inhibitors derived from chestnut and use thereof
JP2010184909A (ja) * 2009-02-13 2010-08-26 Rheology Kino Shokuhin Kenkyusho:Kk 機能性組成物およびこの組成物を含有する医薬又は健康食品
JP2014198684A (ja) * 2013-03-29 2014-10-23 サンスター株式会社 血糖代謝改善剤
JP6998108B2 (ja) 2016-03-07 2022-01-18 株式会社ダイセル ウロリチン類を含有するα－グルコシダーゼ活性阻害剤、およびウロリチン類を含有する血糖値上昇抑制剤
WO2019131759A1 (ja) * 2017-12-27 2019-07-04 サントリーホールディングス株式会社 腸管バリア機能改善用組成物
JPWO2019131759A1 (ja) * 2017-12-27 2020-12-24 サントリーホールディングス株式会社 腸管バリア機能改善用組成物
JP7252904B2 (ja) 2017-12-27 2023-04-05 サントリーホールディングス株式会社 腸管バリア機能改善用組成物
WO2022085602A1 (ja) * 2020-10-20 2022-04-28 サントリーホールディングス株式会社 Ｔｇｒ５活性化用組成物

Also Published As

Publication number Publication date
US20060024396A1 (en) 2006-02-02
WO2002009734A8 (fr) 2002-02-28
EP1312374A4 (en) 2004-04-21
EP1312374B1 (en) 2008-09-10
DE60135760D1 (de) 2008-10-23
CN1268351C (zh) 2006-08-09
CN1468106A (zh) 2004-01-14
AU2001276682A1 (en) 2002-02-13
US6932990B2 (en) 2005-08-23
JP4873824B2 (ja) 2012-02-08
EP1312374A1 (en) 2003-05-21
US20030161903A1 (en) 2003-08-28
ATE407689T1 (de) 2008-09-15

Similar Documents

Publication Publication Date Title
WO2002009734A1 (fr) Inhibiteurs d'absorption de sucre et leur procede de production
Juan-Badaturuge et al. Antioxidant compounds from a South Asian beverage and medicinal plant, Cassia auriculata
Cárdenas-Rodríguez et al. Anticonvulsant and antioxidant effects of Tilia americana var. mexicana and flavonoids constituents in the pentylenetetrazole-induced seizures
EP1569672A1 (fr) Procede de preparation d'un extrait de centella asiatica riche en madecassoside et en terminoloside
KR20080038127A (ko) 아티초크 추출물, 이의 용도와 이를 포함하는 제제
Jung et al. Quantitative HPLC analysis of two key flavonoids and inhibitory activities against aldose reductase from different parts of the Korean thistle, Cirsium maackii
KR101588613B1 (ko) 감귤류에서 노빌레틴 및 탄제레틴 함량이 높은 추출물을 추출하는 방법과 추출물의 용도
Fu et al. Phenolic composition and effects on allergic contact dermatitis of phenolic extracts Sapium sebiferum (L.) Roxb. leaves
FR2905854A1 (fr) Composition a base de xanthoxyline et son utilisation en cosmetique
KR20110017402A (ko) 유칼리 추출물의 조제 방법
KR101541520B1 (ko) 항산화 및 항노화 활성을 갖는 황칠나무, 산수유 및 구기자 혼합 추출물의 제조방법 및 상기 추출물을 유효성분으로 함유하는 화장료 조성물
KR20010052636A (ko) 하이페리쿰 퍼포라툼의 추출물 및 그를 함유한 제제
Samydurai et al. Polyphenols, vitamin-E estimation and in vitro antioxidant activity of Adiantum capillus-veneris
Okaiyeto et al. UPLC-ESI-QTOF-MS phenolic compounds identification and quantification from ethanolic extract of Myrtus communis ‘Variegatha’: In vitro antioxidant and antidiabetic potentials
Kljakić et al. Chemical profiling and biological activities of Opopanax hispidus extracts: A comparative insight on conventional and green extraction technologies
KR0180688B1 (ko) 흑화 성분을 제거하여 개선된 미백효과를 갖는 천문동 비극성 지질 분획 추출물 및 이를 함유하는 기미, 주근깨 개선 및 피부 미백용 조성물
Azari et al. Antioxidants activity of extracts from Sambucus nigra, efficiency of different extraction methods
JP2012031086A (ja) 抗酸化剤及び化粧料
Hashim et al. Antioxidant and α-glucosidase inhibitory constituents from Hornstedtia species of Malaysia
Jiji et al. Neuropharmacological potential of Clitoria ternatea Linn.-A review
EP3922633A1 (fr) Procédé d'extraction des alcaloïdes pyrrolizidiniques
KR20180060609A (ko) 피부 개선용 조성물
Duenas et al. Phenolic composition and antioxidant activity of mocan seeds (Visnea mocanera Lf).
Raduan et al. Antioxidant capabilities of Litsea garciae bark extracts and their relation to the phytochemical compositions
US20020012713A1 (en) Water-soluble complex of an extract of ginkgo biloba, process for the preparation thereof and composition comprising the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page

Free format text: UNDER (72, 75) THE TRANSLITERATION IN JAPANESE OF "4-3-9, KIYOMIDAI, KAWASHINAGANO-SHI, OSAKA 586-0043 (JP)." CORRECTED

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 10343488

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2001954345

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 01816661X

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 2001954345

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 2001954345

Country of ref document: EP